Mixed ligand gold(III) complexes and methods thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9487542
SERIAL NO

14798071

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Gold(III) complexes having mixed ligands as anticancer agents. The atom is coordinated by bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and an ethylenediamine ligand. These complexes can exist in both cis- and trans-configurations. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KING FAHD UNIVERSITY OF PETROLEUM AND MINERALSDHAHRAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al-Jaroudi, Said Qatif-Qudaih, SA 4 9
Al-Saadi, Abdulaziz Dhahran, SA 9 12
Altaf, Muhammad Dhahran, SA 44 54
Isab, Anvarhusein Abdulkadir Dhahran, SA 23 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 8, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00